These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23815603)

  • 21. Oncogenic Mutation of AIMP2/p38 Inhibits Its Tumor-Suppressive Interaction with Smurf2.
    Kim DG; Lee JY; Lee JH; Cho HY; Kang BS; Jang SY; Kim MH; Guo M; Han JM; Kim SJ; Kim S
    Cancer Res; 2016 Jun; 76(11):3422-36. PubMed ID: 27197155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural insight into the interaction between p53 TAD1 and AIMP2-DX2 by NMR.
    Cho HY; Jha R; Mushtaq AU; Oh SH; Jeon YH
    Biochem Biophys Res Commun; 2020 Jun; 527(3):831-838. PubMed ID: 32448505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Data on optimization of expression and purification of AIMP2-DX2 protein in
    Jha R; Cho HY; Mushtaq AU; Lee K; Kim DG; Kim S; Jeon YH
    Data Brief; 2017 Apr; 11():533-536. PubMed ID: 28367482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer.
    Choi JW; Lee JW; Kim JK; Jeon HK; Choi JJ; Kim DG; Kim BG; Nam DH; Kim HJ; Yun SH; Kim S
    J Mol Cell Biol; 2012 Jun; 4(3):164-73. PubMed ID: 22532625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer.
    Ku J; Kim R; Kim D; Kim D; Song S; Lee K; Lee N; Kim M; Yoon SS; Kwon NH; Kim S; Kim Y; Koh Y
    Commun Biol; 2020 Oct; 3(1):630. PubMed ID: 33128014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bi-directional regulation of AIMP2 and its splice variant on PARP-1-dependent neuronal cell death; Therapeutic implication for Parkinson's disease.
    Lee MH; Um KH; Lee SW; Sun YJ; Gu DH; Jo YO; Kim SH; Seol W; Hwang H; Baek K; Choi JW
    Acta Neuropathol Commun; 2024 Jan; 12(1):5. PubMed ID: 38172953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidirectional tumor-suppressive activity of AIMP2/p38 and the enhanced susceptibility of AIMP2 heterozygous mice to carcinogenesis.
    Choi JW; Um JY; Kundu JK; Surh YJ; Kim S
    Carcinogenesis; 2009 Sep; 30(9):1638-44. PubMed ID: 19622630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methionyl-tRNA synthetase and aminoacyl-tRNA synthetases interacting multi-functional protein-lacking exon 2 as potential diagnostic biomarkers for lung cancer.
    Kim T; Lee K; Nahm JH; Kim EY; Lee SH; Chang YS
    Am J Cancer Res; 2021; 11(6):3135-3144. PubMed ID: 34249450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
    Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
    Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lentivirus-AIMP2-DX2 shRNA suppresses cell proliferation by regulating Akt1 signaling pathway in the lungs of AIMP2⁺/⁻ mice.
    Hwang SK; Chang SH; Minai-Tehrani A; Kim YS; Cho MH
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):165-73. PubMed ID: 23517169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
    Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
    Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
    Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.
    Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park H; Lee JY; Nam SW
    J Cell Biochem; 2012 Jun; 113(6):2167-77. PubMed ID: 22492270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.
    LaCasse EC; Cherton-Horvat GG; Hewitt KE; Jerome LJ; Morris SJ; Kandimalla ER; Yu D; Wang H; Wang W; Zhang R; Agrawal S; Gillard JW; Durkin JP
    Clin Cancer Res; 2006 Sep; 12(17):5231-41. PubMed ID: 16951243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
    Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
    Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
    Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
    Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors.
    Fournel M; Trachy-Bourget MC; Yan PT; Kalita A; Bonfils C; Beaulieu C; Frechette S; Leit S; Abou-Khalil E; Woo SH; Delorme D; MacLeod AR; Besterman JM; Li Z
    Cancer Res; 2002 Aug; 62(15):4325-30. PubMed ID: 12154036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.